NDC 0944-4351 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 0944-4351 |
Marketing Category | / |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2008-03-19 |
Marketing End Date | 2015-03-31 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | PLASMA DERIVATIVE |
Marketing Start Date | 2008-03-21 |
Marketing End Date | 2008-03-21 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-01-11 |
Marketing End Date | 2015-03-31 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | PLASMA DERIVATIVE |
Marketing Start Date | 2008-03-19 |
Marketing End Date | 2015-03-31 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2008-03-19 |
Marketing End Date | 2015-03-31 |
Marketing Category | BLA |
Application Number | BLA125266 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-03-08 |
Marketing End Date | 2009-11-30 |